Verified Nov 2026
Batteries & E-Mobility
·
Waltham, Massachusetts
·
Since 1981
Repligen Corporation is a life sciences company headquartered in Waltham, Massachusetts, United States, founded in 1981. It is publicly listed under the ticker RGEN and reports an employee band of 1,000 to 5,000. The company develops bioprocessing technologies, including filtration systems, chromatography columns, and process analytics tools, for biopharmaceutical companies and contract manufacturers. In October 2026 it completed its acquisition of BioLife Solutions, adding biopreservation media to its cell therapy capabilities.
Repligen Corporation at a glance
Revenue
738.3M
Employees
1,000-5,000
Founded
1981
Headquarters
Waltham, Massachusetts
Ownership
Publicly traded (NASDAQ: RGEN)
Certifications
ISO 13485 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & strong
45 years in operation (founded 1981).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
Repligen Corporation is a life sciences company headquartered in Waltham, Massachusetts, United States, founded in 1981. It is publicly listed under the ticker RGEN and reports an employee band of 1,000 to 5,000. The company develops bioprocessing technologies, including filtration systems, chromatography columns, and process analytics tools, for biopharmaceutical companies and contract manufacturers. In October 2026 it completed its acquisition of BioLife Solutions, adding biopreservation media to its cell therapy capabilities.
At a glance
Attribute | Detail |
|---|---|
Founded | 1981 |
Headquarters | Waltham, Massachusetts |
Employees | 1,000-5,000 |
Revenue | 738.3M |
Ownership | Publicly traded (NASDAQ: RGEN) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 9001 |
What Repligen Corporation makes
Its certifications include ISO 13485 and ISO 9001, and its product lines include filtration, chromatography, and process analytics equipment.
Products and capabilities described on the company's own site include Plastic, Injection Molding, Steel (source: repligen.com).
Certifications
Repligen Corporation is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — repligen.com
ISO 9001 — repligen.com
Latest developments
2026-10-30 — Repligen Corporation - Repligen Announces $1 Billion Private Convertible Senior Notes Transaction (repligen.com)
2026-10-27 — Repligen Corporation - Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance (repligen.com)
2026-10-06 — Repligen Corporation - Repligen Completes Acquisition of BioLife Solutions (repligen.com)
2026-07-22 — Repligen Corporation - Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media (repligen.com)
2025-09-16 — Yokogawa and Repligen Partner to Enhance Process Analytical Technology | Yokogawa America (yokogawa.com)
2025-07-31 — Repligen Corporation - Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (repligen.com)
Company details
The company is publicly traded, reports revenue in the range of $738.3 million, and operates in the life sciences and bioprocessing sector. Repligen Corporation was founded in 1981, has an estimated 1,000-5,000 employees, and is headquartered in Waltham, Massachusetts. On the LightSource stability read it is rated "Established & strong": 45 years in operation (founded 1981). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Repligen Corporation make?
Repligen Corporation is a life sciences company headquartered in Waltham, Massachusetts, United States, founded in 1981. It is publicly listed under the ticker RGEN and reports an employee band of 1,000 to 5,000. The company develops bioprocessing technologies, including filtration systems, chromatography columns, and process analytics tools, for biopharmaceutical companies and contract manufacturers. In October 2026 it completed its acquisition of BioLife Solutions, adding biopreservation media to its cell therapy capabilities.
Where is Repligen Corporation headquartered?
Repligen Corporation is headquartered in Waltham, Massachusetts (41 Seyon Street, Waltham, Massachusetts, 02453).
When was Repligen Corporation founded?
Repligen Corporation was founded in 1981.
How big is Repligen Corporation?
Repligen Corporation has an estimated 1,000-5,000 employees, with revenue in the 738.3M range.
Is Repligen Corporation publicly traded?
Publicly traded (NASDAQ: RGEN). Public financial figures are drawn from its filings.
What certifications does Repligen Corporation hold?
Repligen Corporation lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.